Ela joined BDC in 2007 and invested for 9 years in the Healthcare Fund. She brings over 25 years of investing and entrepreneurial experience in the biopharmaceutical industry.
She is currently Program Director with BDC Capital's Market Development team, supporting BDC shareholder programs VCAP ($400 million) and VCCI ($400 million) in fund of funds and high performing funds in Canada. The team is also rolling out new programs that will deliver the necessary tools and training content for venture capital professionals in Canada's ecosystem to accelerate learning and enhance performance of the industry.
Prior to joining BDC, she was Chief Operating Officer and held the position of Vice President in clinical, regulatory affairs, and product strategy for various biotech companies, as well as Senior Vice President for a public pharmaceutical company. Ela's diversified background also includes key involvement in product acquisition and M&A activities.
Education, Personal, and Fellowship
Ela holds an Honours B.Sc. in chemistry from the University of Western Ontario, an M.Sc. in pharmacology from the University of Toronto and an MBA in bio-industries from L'Université du Québec à Montréal (UQAM).
A member of Class 17, Ela served her fellowship at BDC Capital. Committed to advancing investor education in Canada, BDC awards partial scholarships for Kauffman Fellows to leading Canadian investors. Ela also served as mentor to Lesley Esford (Class 20).